Pain AND Opioids After Surgery
The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management
| Condition(s) | Opioid Use, Pain, Chronic, Pain, Postoperative, Quality of Life |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week afte |
| Who can participate | Inclusion Criteria: * hospitalised adult patients (18 years and older) undergoing any inpatient surgery (elective or emergency) during the designated study week where an anaesthetist is involved (general anaesthetic, sedation, local anaesthetic). Able to understand and has capacity to give written informed consent Exclusion Criteria: * American Society of Anaesthesiologists (ASA) grade V or VI * Refusal to participate. * Lack of comprehension of validated questionnaires or inability to complete the follow-up for any reason. * Lack of capacity to give written informed consent |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Aberdeen |
| Locations | Zagreb, Vinogradska 29, Croatia; Aberdeen, United Kingdom; London, United Kingdom; Nottingham, United Kingdom |
| Start date | 2023-09-25 |
| NCT ID | NCT05877157 |
| Official listing | https://clinicaltrials.gov/study/NCT05877157 |